Insider Transactions in Q4 2020 at Immunomedics Inc (IMMU)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2020
|
Barbara Gayle Duncan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
49,244
-100.0%
|
-
|
|
Oct 23
2020
|
Charles M Baum Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,667
-100.0%
|
-
|
|
Oct 23
2020
|
Bryan Ball Chief Quality Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-100.0%
|
-
|
|
Oct 23
2020
|
Khalid Islam Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Lorettta M Itri Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-100.0%
|
-
|
|
Oct 23
2020
|
Peter Barton Hutt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Scott A Canute Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|
|
Oct 23
2020
|
Usama Malik Chief Fin. & Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,856
-100.0%
|
-
|
|
Oct 23
2020
|
Behzad Aghazadeh Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
26,250,000
-100.0%
|
-
|
|
Oct 23
2020
|
Behzad Aghazadeh Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,516
-100.0%
|
-
|